Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase II Study of High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies (Cohort B)

Summary

The purpose of this phase II trial (Cohort B) is to evaluate the safety and efficacy of high dose Vitamin C in patients with metastatic solid tumors, including pancreatic cancer, with extended RAS (e.g. KRAS or NRAS) or BRAF mutation and who have received prior systemic treatment.

General Information

NCT#: NCT03146962
Study ID: 1610017688
Trial Phase: Phase II

Trial Sponsor: Weill Medical College of Cornell University
Therapies Used in This Trial: Ascorbic Acid

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search